Glaxo (GSK), Human Genome's (HGSI) Benlysta Wins Backing of FDA Advisory Panel
Tweet Send to a Friend
An FDA panel has recommended approval of GlaxoSmithKline (NYSE: GSK) and Human Genome Sciences (Nasdaq: HGSI) new lupus treatment Benlysta ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
